Draft User Fee Bill’s GMP Shortcut for Shortage Drugs Provides Balance: Expert

Drug Industry Daily
Drugmakers may soon be able to get critical shortage drugs to market faster with a proposed shortcut for proving manufacturing compliance that’s included in draft legislation to reauthorize the FDA’s user fee programs.

To View This Article:


Subscribe To Drug Industry Daily